Zhongnan Medical Journal Press

Home Results

A total of 26 result was found. Results that relate to Effectiveness

Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2025,35(4):442-451.
9290 times 1583 times

WANG Kuan TAN Xiao GUO Yanni

Non-small cell lung cancer Tislelizumab Chemotherapy Effectiveness Safety Meta-analysis
Details
Pharmacoeconomic evaluation of ribociclib plus fulvestrant in second-line treatment of HR+/HER2- advanced breast cancer for postmenopausal women

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):612-620.
8651 times 1352 times

JIA Caifeng WANG Jie ZHANG Sen WANG Meiqi LI Sainan WANG Mingxia

Ribociclib Fulvestrant Advanced breast cancer Postmenopausal Pharmacoeconomic evaluation Cost-effectiveness analysis
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):690-701.
13686 times 1712 times

ZHANG Bin LIU Minna LI Xiaolin LI Jinhu LIU Tianlong

National centralized drug procurement Real world study Clinical evaluation Generic drugs Innovator drugs Effectiveness Safety
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
7526 times 1110 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
9983 times 1129 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
4665 times 835 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
2867 times 529 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Application progress of paraben preservatives in pharmaceutical preparations

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2145-2153.
2345 times 370 times

YI Qiao WANG Jie YAN Leina

Paraben Antimicrobial effectiveness Safety Methylparaben Ethylparaben Bacteriostat Dosage
Details
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):192-199.
1387 times 267 times

GU Shilong ZHANG Wenjing GUO Hao

Mepolizumab Refractory chronic rhinosinusitis with nasal polyps Effectiveness safety Cost-effectiveness
Details
Evaluation of the pharmacoeconomics of recombinant human thrombopoietin for the treatment of cancer therapy-induced thrombocytopenia

Published on Chinese Journal of Pharmacoepidemiology New Online
529 times 181 times

LIANG Hai XIA Runan CHEN Huijuan JIANG Mengyu LI Fanqin YANG Miao MA Jinghe

Recombinant human thrombopoietin Interleukin-11 Cancer Thrombocytopenia Decision tree Cost-effectiveness analysis
Details
Cost-effectiveness analysis of fondaparinux compared with low molecular-weight heparin in the treatment of recurrent spontaneous abortion

Published on Chinese Journal of Pharmacoepidemiology 2026,35(3):281-287.
583 times 185 times

ZHU Yurong LI Lanlan ZHANG Rui DAI Wei YANG Weihu

Recurrent spontaneous abortion Fondaparinux Low molecular-weight heparin Cost-effectiveness analysis
Details